Morgan Stanley’s Merus Labs International Inc. MSLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-756,100
| Closed | -$953K | – | 6777 |
|
|
2017
Q2 | $953K | Buy |
756,100
+719,100
| +1,944% | +$746K | ﹤0.01% | 4403 |
|
|
2017
Q1 | $34K | Sell |
37,000
-137,300
| -79% | -$118K | ﹤0.01% | 5943 |
|
|
2016
Q4 | $152K | Sell |
174,300
-177,600
| -50% | -$163K | ﹤0.01% | 5441 |
|
|
2016
Q3 | $362K | Buy |
351,900
+82,625
| +31% | +$93.3K | ﹤0.01% | 4716 |
|
|
2016
Q2 | $345K | Buy |
269,275
+52,191
| +24% | +$72.9K | ﹤0.01% | 4640 |
|
|
2016
Q1 | $319K | Buy |
217,084
+196,607
| +960% | +$273K | ﹤0.01% | 4696 |
|
|
2015
Q4 | $34K | Sell |
20,477
-6,694
| -25% | -$9.11K | ﹤0.01% | 5863 |
|
|
2015
Q3 | $35K | Sell |
27,171
-111,703
| -80% | -$222K | ﹤0.01% | 5859 |
|
|
2015
Q2 | $323K | Buy |
138,874
+107,437
| +342% | +$261K | ﹤0.01% | 4976 |
|
|
2015
Q1 | $66K | Buy |
31,437
+31,300
| +22,847% | +$57.7K | ﹤0.01% | 5690 |
|
|
2014
Q4 | $0 | Hold |
137
| – | – | ﹤0.01% | 6781 |
|
|
2014
Q3 | $0 | Sell |
137
-15,200
| -99% | -$30.9K | ﹤0.01% | 6759 |
|
|
2014
Q2 | $34K | Buy |
15,337
+14,872
| +3,198% | +$25K | ﹤0.01% | 5886 |
|
|
2014
Q1 | $1K | Buy |
+465
| New | +$664 | ﹤0.01% | 6419 |
|
Morgan Stanley's MSLI Position: Q3 2017 in Review
Morgan Stanley sold out of Merus Labs International Inc. (MSLI) in Q3 2017, closing a stake of 756,100 shares — an estimated $953K sold.
Morgan Stanley first reported a position in MSLI in Q1 2014 and held it in 14 quarters. The position peaked at $953K in Q2 2017. 0 funds tracked by Wall St. Rank hold MSLI as of Q3 2017.
- Morgan Stanley reported no remaining Merus Labs International Inc. position as of Q3 2017 after selling out during the quarter.
- Morgan Stanley sold 756,100 Merus Labs International Inc. shares in Q3 2017, an estimated $953K.
- Morgan Stanley first reported a position in Merus Labs International Inc. in Q1 2014 and held it in 14 quarters.
- Morgan Stanley's Merus Labs International Inc. position peaked at $953K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Merus Labs International Inc. as of Q3 2017.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.